Brief: Statera Biopharma Reports Q3 Loss Per Share $0.47
15/11/2021 21:23
Nov 15 (Reuters) - Statera Biopharma Inc STAB.O :
* Q3 LOSS PER SHARE $0.47
* AT SEPTEMBER 30, 2021, STATERA BIOPHARMA REPORTED CASH,
CASH
EQUIVALENTS, AND RESTRICTED CASH OF $14.4 MILLION
Source text for Eikon: ID:nGNX1zzpHj
Further company coverage: STAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc